Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
Open Access
- 24 April 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (4), e35511
- https://doi.org/10.1371/journal.pone.0035511
Abstract
An increase in apoptotic events may underlie neuropathology in schizophrenia. By data-mining approaches, we identified significant expression changes in death receptor signaling pathways in the dorsolateral prefrontal cortex (DLPFC) of patients with schizophrenia, particularly implicating the Tumor Necrosis Factor Superfamily member 6 (FAS) receptor and the Tumor Necrosis Factor [ligand] Superfamily member 13 (TNFSF13) in schizophrenia. We sought to confirm and replicate in an independent tissue collection the noted mRNA changes with quantitative real-time RT-PCR. To test for regional and diagnostic specificity, tissue from orbital frontal cortex (OFC) was examined and a bipolar disorder group included. In schizophrenia, we confirmed and replicated significantly increased expression of TNFSF13 mRNA in the DLPFC. Also, a significantly larger proportion of subjects in the schizophrenia group had elevated FAS receptor expression in the DLPFC relative to unaffected controls. These changes were not observed in the bipolar disorder group. In the OFC, there were no significant differences in TNFSF13 or FAS receptor mRNA expression. Decreases in BH3 interacting domain death agonist (BID) mRNA transcript levels were found in the schizophrenia and bipolar disorder groups affecting both the DLPFC and the OFC. We tested if TNFSF13 mRNA expression correlated with neuronal mRNAs in the DLPFC, and found significant negative correlations with interneuron markers, parvalbumin and somatostatin, and a positive correlation with PPP1R9B (spinophilin), but not DLG4 (PSD-95). The expression of TNFSF13 mRNA in DLPFC correlated negatively with tissue pH, but decreasing pH in cultured cells did not cause increased TNFSF13 mRNA nor did exogenous TNFSF13 decrease pH. We concluded that increased TNFSF13 expression may be one of several cell-death cytokine abnormalities that contribute to the observed brain pathology in schizophrenia, and while increased TNFSF13 may be associated with lower brain pH, the change is not necessarily causally related to brain pH.Keywords
This publication has 76 references indexed in Scilit:
- Common variants conferring risk of schizophrenia: A pathway analysis of GWAS dataSchizophrenia Research, 2010
- Alterations of Cortical GABA Neurons and Network Oscillations in SchizophreniaCurrent Psychiatry Reports, 2010
- Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophreniaBMC Psychiatry, 2009
- The Stanley Neuropathology Consortium Integrative Database: a Novel, Web-Based Tool for Exploring Neuropathological Markers in Psychiatric Disorders and the Biological Processes Associated with Abnormalities of Those MarkersNeuropsychopharmacology, 2009
- Site-specific regulation of cell cycle and DNA repair in post-mitotic GABA cells in schizophrenic versus bipolarsProceedings of the National Academy of Sciences of the United States of America, 2009
- Reduced Dendritic Spine Density in Auditory Cortex of Subjects with SchizophreniaNeuropsychopharmacology, 2008
- Conserved Regional Patterns of GABA-Related Transcript Expression in the Neocortex of Subjects With SchizophreniaAmerican Journal of Psychiatry, 2008
- Alterations in Somatostatin mRNA Expression in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia or Schizoaffective DisorderCerebral Cortex, 2008
- DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophreniaSchizophrenia Research, 2007
- Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophreniaMolecular Psychiatry, 2007